Aulos Co-founders
Aulos™ was co-founded by Biolojic Design and ATP, with $60 million in Series A funding from ATP. The company is led by pioneers in the fields of artificial intelligence, antibody development and cancer immunotherapies.
Aulos™ was co-founded by Biolojic Design and ATP, with $60 million in Series A funding from ATP. The company is led by pioneers in the fields of artificial intelligence, antibody development and cancer immunotherapies.